Related Experiment Video
Updated: Jan 5, 2026
05:59
Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
3.0K
Recent advances in treatment for narcolepsy
Lucie Barateau1, Yves Dauvilliers2
1Service de Neurologie, Gui-de-Chauliac Hospital, Montpellier, France; Sleep-Wake Disorders Center, Gui-de-Chauliac Hospital, CHU Montpellier, France; National Reference Network for Narcolepsy, Montpellier, France; Inserm U1061, Montpellier, France.
Therapeutic Advances in Neurological Disorders
|October 22, 2019
Summary
Narcolepsy treatments are evolving, with new drugs targeting excessive daytime sleepiness and exploring orexin-based therapies. Personalized medicine approaches may offer future hope for this rare neurological disorder.
Area of Science:
- Neurology
- Sleep Medicine
- Pharmacology
Background:
- Narcolepsy type 1 (NT1) results from hypocretin/orexin (ORX) neuron loss, likely autoimmune. Narcolepsy type 2 (NT2) shares symptoms like excessive daytime sleepiness (EDS) but lacks cataplexy and ORX neuron loss.
- Current NT1 and NT2 management primarily offers symptomatic relief for EDS, often using psychostimulants.
Purpose of the Study:
- To review current and emerging therapeutic strategies for narcolepsy, focusing on novel pharmacological agents and personalized medicine.
- To highlight advancements in understanding narcolepsy's neurobiology and its implications for treatment development.
Main Methods:
- Review of recent pharmacological developments and clinical trial outcomes for narcolepsy treatments.
- Analysis of the neurobiological underpinnings of narcolepsy and their translation into therapeutic targets.
Main Results:
- New wake-promoting agents like pitolisant and solriamfetol offer improved EDS management for both NT1 and NT2.
- Sodium oxybate demonstrates efficacy in childhood narcolepsy. Orexin-based therapies and immune-based interventions are under development.
- Narcolepsy serves as a model for personalized medicine in orphan diseases due to its diverse profiles.
Conclusions:
- Narcolepsy treatment is advancing beyond symptomatic management with novel drugs and targeted therapies.
- Future research should focus on personalized medicine approaches to optimize treatment based on individual patient profiles.
- Early immune-based interventions may hold potential for halting disease progression in specific narcolepsy cases.
Keywords:
cataplexyhypocretin/orexinimmune-based therapiesnarcolepsy type 1narcolepsy type 2sleepinessMore Related Videos
Related Concept Videos
01:07Narcolepsy
453
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
453
01:24Sleep-Wake Cycles
2.6K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
2.6K
01:19Management of Insomnia
487
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
487
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
468
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
468
01:15REM Sleep Behavior Disorder
1.2K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
1.2K
01:24Substance Use Disorders Affecting Sleep
352
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
352